Modulim featured as Showcase company by National Institute of Aging
Modulated Imaging (dba Modulim) was recently highlighted by National Institute of Aging (NIA) as a showcase company. Modulim successfully completed a Phase 2 Small Business Innovation Research (SBIR) program with the National Institute of Aging (NIA) to conduct R&D and build a system that brings Spatial Frequency Domain Imaging (SFDI) to the point-of-care for chronic wound management. […]
Modulim Announces CE Mark of Clarifi® Imaging System for Microvascular Assessment
Irvine, CA—December 2, 2020 Modulim, the global leader in optical imaging solutions for the non-invasive assessment of tissue and vascular health, announced today that Clarifi® has received CE Mark certification. This allows Modulim to now expand its marketing and distribution throughout Europe and apply for registration in other international markets that recognize the CE Mark. Powered by […]
Modulim Supports Development of Optical Technologies for Soldiers on the Battlefield
July 1, 2020 Check out this article detailing research using optical technologies to help manage soldiers health on battlefield. We are grateful to partner with the Beckman Laser Institute and support their efforts to build optical technologies for our soldiers in work funded by the Air Force Office of Scientific Research (AFOSR). Modulim’s SFDI technology was invented […]
Spatial Frequency Domain Imaging (SFDI) Revenue Cycle Processes
February 3, 2020 Modulim’s new proprietary CPT code 0061U was highlighted by Kathleen Schaum, in Today’s Wound Clinic. The code can be used for capturing five transcutaneous hemoglobin biomarkers using SFDI, the core technology used in the Clarifi Imaging System. The biomarkers can be used by clinicians for microvascular assessment and identifying potential compromised circulation due […]
Modulim Granted CPT Code from the American Medical Association for its Noninvasive Microvascular Assessment Technology
Irvine, CA — July 30, 2019 (BUSINESS WIRE) — Modulim, the global leader in noninvasive microvascular assessment using spatial frequency domain imaging (SFDI), has announced that the American Medical Association (AMA) has granted a Current Procedural Terminology (CPT®) Proprietary Laboratory Analyses (PLA) Code (0061U) for the transcutaneous measurement of tissue oxygenation and hemoglobin using SFDI. The CPT code […]
Journal of Biomedical Optics Modulim’s Founder and VP of R&D Guest Editors for Special Section on SFDI Technology
July 2019 The Journal of Biomedical Optics recently featured a special section on Spatial Frequency Domain Imaging (SFDI). Our founder & CTO, David Cuccia, and our VP of R&D, Amaan Mazhar, served as guest editors for the special section. The section includes fourteen articles that covered a number of topics related to the use and development of […]
Modulim’s Poster at the International Symposium on the Diabetic Foot Highlighted Microcirculation Measurements of Subjects in Ulcer Remission
The 8th International Symposium on the Diabetic Foot (ISDF), held every four years, took place last week from May 22-25 at The Hague in the Netherlands. As the largest and most prestigious international meeting devoted to lower extremity problems in diabetes, leading experts from around the world came together to participate in plenary sessions, poster discussions, workshops, […]
New Study Finds SFDI a Promising Technology for Assessing Patients At-Risk of PAD
IRVINE, Calif.–April 23, 2019 – (BUSINESS WIRE)– Modulim, a recognized leader in SFDI-based optical imaging solutions for the non-invasive assessment of tissue health, has announced the findings of a recent study published in the Journal of Vascular Surgery. The study describes Modulim’s SFDI-based technology as a promising non-invasive optical imaging method for rapidly assessing compromised circulation in tissue in the lower extremity of patients with and […]
ISO 13485 Certification Awarded to Modulated Imaging
IRVINE, CA – May 1, 2018 Modulated Imaging, the leader in optical imaging solutions powered by Spatial Frequency Domain Imaging (SFDI) for noninvasive assessment of tissue health, has been awarded International Organization for Standardization (ISO) 13485:2016 certification for its medical device Quality Management System. Modulated Imaging’s FDA-cleared medical device, Ox-Imager CS®, helps clinicians identify patients with compromised […]
FDA Clearance Received for Ox-Imager CS System
Irvine, CA – January 18, 2017 Modulated Imaging, Inc. announced today that it has received clearance from the FDA for its Ox-Imager CS technology. This device is designed to assist clinicians with the identification of lower limb vascular issues, so that patients can receive appropriate, timely treatment. With FDA authorization, Modulated Imaging can now launch […]